SCHEMBL3107797

SCHEMBL3107797

O=C(c1ccc(Cl)cc1)N1CCN(C2CN(C(=O)c3ccc(F)c(Cl)c3)CC2O)CC1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 4/20 0.46
HSP90AA1 P07900 1/20 0.45
POLB P06746 1/20 0.45
SLC18A3 Q16572 3/20 0.44
HSD11B1 P28845 1/20 0.44
HTR1A P08908 1/20 0.43
KMT2A Q03164 2/20 0.43
MAPT P10636 1/20 0.42
MEN1 O00255 1/20 0.42
HPGD P15428 2/20 0.42
PHGDH O43175 1/20 0.42
ALDH1A1 P00352 1/20 0.42
HSD17B10 Q99714 1/20 0.42
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
CA14 Q9ULX7 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13157845 1.00 MGLL (0.46) MGLLHSP90AA1POLBSLC18A3HSD11B1
SCHEMBL13157762 0.92 MGLL (0.45) MGLLHSP90AA1POLBSLC18A3HSD11B1
SCHEMBL3104941 0.92 MGLL (0.45) MGLLHSP90AA1POLBSLC18A3HSD11B1
SCHEMBL13157952 0.92 KMT2A (0.52) MGLLHSP90AA1POLBSLC18A3HSD11B1
SCHEMBL13157849 0.92 KMT2A (0.52) MGLLHSP90AA1POLBSLC18A3HSD11B1
SCHEMBL3100951 0.92 KMT2A (0.52) MGLLHSP90AA1POLBSLC18A3HSD11B1
SCHEMBL3098323 0.92 KMT2A (0.52) MGLLHSP90AA1POLBSLC18A3HSD11B1
SCHEMBL13157795 0.89 POLB (0.55) MGLLHSP90AA1POLBSLC18A3KMT2A
SCHEMBL13158203 0.89 POLB (0.55) MGLLHSP90AA1POLBSLC18A3KMT2A
SCHEMBL3105142 0.89 POLB (0.55) MGLLHSP90AA1POLBSLC18A3KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8399455-B2 Compounds useful as chemokine receptor antagonists MILLENNIUM PHARMACEUTICALS, INC. (US) 2013-03-19 US disclosed
US-20100234356-A1 COMPOUNDS USEFUL AS CHEMOKINE RECEPTOR ANTAGONISTS MILLENNIUM PHARMACEUTICALS, INC. (US) 2010-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234356-A1 COMPOUNDS USEFUL AS CHEMOKINE RECEPTOR ANTAGONISTS ACKR3, CCR5, CXCR2 MGLL 2345/4885HSP90AA1 3474/4885POLB 3618/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.